I recently had a conversation with Chas Pulido and Dennis Gong of Alix Ventures for the BIOS Podcast where we discussed how scientists thinking about starting companies can appeal to investors, including how we think about it at True.
I also shared how True started investing in startups tackling problems in human health and biology, as well as our founder-focused investment model that’s guided us since day one.
The conversation was fun and hopefully provides some context for scientist-founders and investors looking to spend more time in this space.
Listen here:
Life in Beta 